Literature DB >> 30169916

Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome-wide association and next generation sequence analysis.

Y Sun1,2,3,4, H Liu1,2,3,4, B Yang1,2, C Wang2,4, J N Foo5, F Bao2,4, A Irwanto5, G Yu2,4, X Fu2,4, Z Wang2,4, J You2,4, J Liu5, G Zhou1,2, J Liu5, F Zhang1,2,3,4,6.   

Abstract

BACKGROUND: Pemphigus is an autoimmune blistering disease with pemphigus vulgaris (PV) and foliaceus (PF) as the two major histological subtypes. Associations with HLA molecules have been suggested, but specific HLA risk variants as well as non-HLA risk variants remain to be discovered.
METHODS: We performed a two-stage genome-wide association study in the Chinese Han population through a genome-wide discovery analysis and follow-up validation analysis in a total number of 210 PV, 159 PF and 2493 healthy controls. HLA imputation as well as high coverage next generation sequencing based HLA genotyping was employed to investigate the association of classical HLA alleles and amino acid change.
RESULTS: We have discovered independent novel associations with PF at rs2178077 on 12q24.33, located next to RAN (PPF = 1.57 × 10-9 ) and rs3888722 within the MHC region (P = 6.73 × 10-9 ). For the HLA variants, we confirmed independent genome-wide level risk associations in HLA-DQB1 and HLA-DRB1, with DQB1*05:03 to be the strongest association with PV (P = 8.59 × 10-68 , OR = 31.16) and PF (P = 4.84 × 10-17 , OR = 5.64). In addition, DRB1*14 was demonstrated to be a second independent variants (P = 4.2 × 10-63 , OR = 35.47) for PV, while DRB1*04:06 was demonstrated to be the second independent signal (P = 7.44 × 10-13 , OR = 5.58) for PF.
CONCLUSIONS: These findings advance our understanding of the genetic basis of pemphigus susceptibility and may offer opportunities for risk prediction and preventive treatment for pemphigus, in particular for PV.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30169916     DOI: 10.1111/jdv.15227

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

Review 1.  Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases.

Authors:  Michael Olbrich; Axel Künstner; Mareike Witte; Hauke Busch; Anke Fähnrich
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

Review 2.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 4.  Epidemiology of Pemphigus.

Authors:  Khalaf Kridin; Enno Schmidt
Journal:  JID Innov       Date:  2021-02-20

Review 5.  Translational autoimmunity in pemphigus and the role of novel Bruton tyrosine kinase inhibitors.

Authors:  Piyu Parth Naik
Journal:  J Transl Autoimmun       Date:  2022-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.